Respiratory adverse effects of Sofosbuvir-based regimens for treatment of chronic hepatitis C virus
Conclusion Sofosbuvir-based regimens used for treatment of chronic HCV infection are considered safe with minor respiratory adverse effects. However, larger multicenter studies are required for further assessment. Graphical abstract
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research
More News: Bronchitis | Bronchoscopy | Cough | CT Scan | Electrocardiogram | Hepatitis | Hepatitis C | Laboratory Medicine | Liver | Liver Disease | Respiratory Medicine | Spirometry | Statistics | Study | Tuberculosis | Ultrasound | Urology & Nephrology